Canada markets open in 8 hours 51 minutes

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.5000+0.0100 (+0.22%)
At close: 04:00PM EDT
4.6100 +0.11 (+2.44%)
After hours: 04:24PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-09-30
2022-09-30
2021-09-30
2020-09-30
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
39,176
43,717
37,916
32,984
25,232
Selling General and Administrative
11,238
12,039
13,070
9,018
5,857
Total Operating Expenses
50,414
55,731
50,986
41,948
30,938
Operating Income or Loss
-50,414
-55,731
-50,986
-41,948
-30,938
Interest Expense
0
964
0
0
-
Total Other Income/Expenses Net
2,438
2,678
2,419
4,281
4,501
Income Before Tax
-40,426
-47,498
-47,620
-37,641
-26,258
Income Tax Expense
168
7
358
268
22.664
Income from Continuing Operations
-40,594
-47,505
-47,978
-37,909
-26,280
Net Income
-40,594
-47,505
-47,978
-37,909
-26,280
Net Income available to common shareholders
-40,594
-47,505
-47,978
-37,909
-26,280
Basic EPS
-0.60
-0.60
-0.62
-0.54
-0.45
Diluted EPS
-0.60
-0.60
-0.62
-0.54
-0.45
Basic Average Shares
79,788
79,788
76,910
69,803
58,195
Diluted Average Shares
79,788
79,788
76,910
69,803
58,195